(547b) Sunflower Therapeutics: Starting a Public Benefit Corporation in Biotech

Sunflower Therapeutics, PBC is a unique biotech company with a mission to enable more medicines to reach patients worldwide. Our goal is to transform access to biologic medicines for patients worldwide by creating novel technologies for development and manufacturing with the whole global community in mind. We are currently developing ‘right-sized’ and efficient approaches to manufacturing proteins using strain engineering, integrated process development, and automated multi-product facilities.

Our approach to business is different. As a Public Benefit Corporation, we aim to achieve profitability while progressing toward our company’s social mission and goals. Our specific public benefit purpose is to increase the global accessibility of health and wellness products. Sunflower is a 100% bootstrapped Women-Owned Small Business and has had positive cash flow since operationalization in 2019.

This presentation will discuss the core technologies behind Sunflower’s approach to ‘right-sized’ multi-product manufacturing, as well as our path to commercialization. We will highlight key strategic decisions in building our mission-focused company, including incorporating as a Public Benefit Corporation and pursuing alternative funding strategies.

Sunflowers are a global symbol of health and wellness. From one small seed grows a tall, hardy flower and one flower can give a thousand seeds. We believe our approach to accessible manufacturing can similarly provide a sustainable ‘harvest’ of products for patients previously without treatment.